CORVAS INC has a total of 12 patent applications. Its first patent ever was published in 1989. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are BERNETT MATTHEW J, AFFIMED THERAPEUTICS AG and CARLBIOTECH LTD AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Australia | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Denmark | 1 | |
#6 | Norway | 1 | |
#7 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Pepe Michael G | 9 |
#2 | Edgington T Scott | 6 |
#3 | Soule Howard R | 1 |
#4 | Webb Thomas R | 1 |
#5 | Pepe Michael Gary | 1 |
#6 | Edgington Thomas Scott | 1 |
#7 | Brunck Terence K | 1 |
Publication | Filing date | Title |
---|---|---|
US5283293A | Reagents for automated synthesis of peptide analogs | |
DK611089D0 | Activity site inhibitors for factor vii / viia | |
WO9003390A1 | Peptidyl inhibitors of the initiation of coagulation | |
US5023236A | Factor VII/VIIA active site inhibitors |